Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical glycopyrrolate 2% for axillary sweating in healthy volunteers
2012-002393-32Phase 2Completed
- Sponsor
- L'Oréal Research & Innovation
- Start
- Jun 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in essential axillary hyperhidrosis comparing Topical glycopyrrolate 2% with Topical placebo (2 arms). Primary endpoint: Reduction in sweat production. Started Jun 2012; status: completed.
02
Drugs
glycopyrronium
03
Conditions
essential axillary hyperhidrosis
Beyond the preview
Go deeper on 2012-002393-32.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-002393-32.